ACR/ARHP Poster Session C 2003. Effects of Opioid and Neurotoxin Analgesics on Pain Behaviors and Function Over Time in Mice with Collagenase-Induced Osteoarthritis. Hollis E. Krug 1 , Christopher W. Dorman 2 , Sandra Frizelle 2 and Maren L. Mahowald 3 , 1 Minneapolis VA Health Care System and University of Minnesota Medical School, Minneapolis, MN, 2 Minneapolis VA Health Care System, Minneapolis, MN, 3 University of Minnesota Medical School and Minneapolis VA Health Care System, Minneapolis, MN 2004. Validation of the Longitudinal Reproducibility of Medial Joint Space Width Quantification in Knee Osteoarthritis. Berna Goker 1 , Tayfun Akalin 1 and Joel A. Block 2 , 1 Gazi University Medical School, Ankara, Turkey, 2 Rush University Medical Center, Chicago, IL 2005. Validity of within-Grade Scoring of Longitudinal Changes of MRI-Based Cartilage Morphology and Bone Marrow Lesion Assessment - the MOST Study. Frank Roemer 1 , Michael C. Nevitt 2 , David T. Felson 3 , Jingbo Niu 1 , John Lynch 4 , Michel Crema 1 , Cora E. Lewis 5 , James Torner 6 and Ali Guermazi 7 , 1 Boston University, Boston, MA, 2 University of California-San Francisco, San Francisco, CA, 3 Department of Clinical Epidemiology, Boston University School of Public Health, Boston, MA, USA, Boston, MA, 4 San Francisco, CA, 5 University of Alabama, Birmingham City, Birmingham, AL, 6 University of Iowa, Iowa City, Iowa City, IA, 7 Boston Medical Center, Boston, MA 2006. Similar Reliability of DESS and TSE Magnetic Resonance Imaging Sequences in the Assessment of Bone Marrow Lesions in Knee Osteoarthritis Patients: Data From the Osteoarthritis Initiative Cohort. Jean-Pierre Raynauld 1 , Lukas M. Wildi 1 , François Abram 2 , Thomas Moser 3 , Manon Girard 2 , Johanne Martel-Pelletier 1 and Jean Pierre Pelletier 1 , 1 Osteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM), Notre-Dame Hospital, Montreal, QC, 2 ArthroVision Inc., Montreal, QC, 3 Department of Radiology, University of Montreal Hospital Centre (CHUM), Notre-Dame Hospital, Montreal, QC Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Rheumatology Systemic Lupus Erythematosus, Juvenile Dermatomyositis, Vasculitis and Other 2007. The Childhood Myositis Assessment Scale (CMAS) Total Score in Healthy Children, Age 4-5 Years, is 46, Not 52. Rebecca Quinones 1 , Gabrielle Morgan 1 , Maria Amoruso 1 , Deli Wang 2 and Lauren M. Pachman 3 , 1 Children’s Memorial Hospital, Chicago, IL, 2 Northwestern University’s Feinberg School of Medicine, Chicago, IL, 3 Northwestern University Feinberg School of Medicine, Chicago, IL 2008. The Pediatric Automated Neuropsychological Assessment Metrics Has Reproducibility and Criterion Validity in Childhood-Onset Lupus. Hermine Brunner 1 , Aimee Baker 1 , Adlin Cedeno 2 , Jennifer L. Huggins 1 , Anna Carmela P. Sagcal- Gironella 3 , Jun Ying 4 , Marisa Klein-Gitelman 2 and Tresa Roebuck-Spencer 5 , 1 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 2 Children’s Memorial Hospital, Chicago, IL, 3 Cincinnati Children’s Hospital, Cincinnati, OH, 4 University of Cincinnati, Cincinnati, OH, 5 University of Oklahoma, Norman, OK 2009. Therapeutic APPROACHES for the TREATMENT of NEW Onset and Flared Juvenile Systemic LUPUS Erythematosus with ACTIVE Renal DISEASE: AN International MULTICENTER PRINTO STUDY. Paivi Miettunen, Angela Pistorio, Angelo Ravelli, Sheila Oliveira, Maria Alessio, Ruben Cuttica, Dimitrina Mihaylova, Graciela Espada, Srdjan Pasic, Elisabetta Cortis, Seza Ozen, Oscar Porras, Flavio Sztajnbok, Alberto Martini and Nicolino Ruperto, IRCCS G. Gaslini, Pediatria II, PRINTO, Paediatric Rheumatology, Genova, Italy 2010. Race, Ethnicity and Gender Affect the Severity of Renal Outcomes in Patients with Pediatric Systemic Lupus Erythematosus: An Analysis of the CARRAnet Data At Baseline Visit. Ornella J. Rullo 1 , Deborah K. McCurdy 1 , Ora Yadin 1 , Alice DC Hoftman 1 , Jennifer M.P. Woo 1 , Emily von Scheven 2 and CARRAnet Investigators 3 , 1 Mattel Children’s Hospital, University of California, Los Angeles, Los Angeles, CA, 2 UC San Francisco, San Francisco, CA, 3 Durham 2011. Behavior, Executive and Perceived Neuropsychological Functioning with Childhood-Onset Systemic Lupus Erythematosus – Results of a Best-Friend Controlled Study. Adlin Cedeno 1 , Aimee Baker 2 , Marisa Klein-Gitelman 1 , Anna Carmela P. Sagcal-Gironella 2 , April German 2 , Cynthia Scharf 2 , Jun Ying 3 , Hermine Brunner 2 , Dean Beebe 2 and Frank Zelko 1 , 1 Children’s Memorial Hospital, Chicago, IL, 2 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 3 University of Cincinnati, Cincinnati, OH 2012. The PRINTO Provisional Definition of REMISSION In Juvenile Dermatomyositis. Dragana Lazarevic 1 , Angela Pistorio 1 , Paivi Miettunen 1 , Angelo Ravelli 1 , Clara Malattia 1 , Clarissa Pilkington 1 , Nico Wulffraat 1 , Stella Maris Garay 1 , Michael Hofer 1 , Pierre Quartier 1 , Pavla Dolezalova 1 , Inmaculada Calvo Penades 1 , Virginia P.L. Ferriani 1 , Gerd Ganser 2 , Ozgur Kasapcopur 1 , Jose Antonio Melo-Gomes 1 , Malgorzata Wierzbowska 1 , Alberto Martini 1 and Nicolino Ruperto 1 , 1 IRCCS G. Gaslini, Pediatria II, PRINTO, Paediatric Rheumatology, Genova, Italy, 2 Sankt Josef Stift, Sendenhorst, Germany 2013. Determination of Pediatric Doses of Colchicine for Familial Mediterranean Fever on the Basis of Population Pharmacokinetics. Yackov Berkun 1 , Eldad Ben-Chetrit 1 , Suman Wason 2 , Robert Faulkner 2 and Stephen Levenstein 3 , 1 Hadassah Hebrew University Medical Center, Jerusalem, Israel, 2 URL Pharma, Philadelphia, PA, 3 GCP Clinical Studies Ltd., Rosh Ha’Ayin, Israel 2014. Performance of the Systemic Lupus Erythematosus Responder Index in Juvenile Systemic Lupus Erythematosus. Rina Mina 1 , Marisa Klein-Gitelman 2 , Shannen L. Nelson 3 , B. Anne Eberhard 4 , Gloria C. Higgins 5 , Nora G. Singer 6 , Deborah M. Levy 7 , Karen Onel 8 , Judyann C. Olson 9 , Joshua D. Pendl 10 , Aimee Baker 10 , Lisa F. Imundo 11 , Lori B. Tucker 12 , Laura E. Schanberg 13 , Marilynn G. Punaro 14 , 270 2011 <strong>Program</strong> <strong>Book</strong>
ACR/ARHP Poster Session C Kathleen M. O’Neil 15 , Nicolino Ruperto 16 , Daniel J. Lovell 10 and Hermine Brunner 10 , 1 Cincinnati Children’s Med Ctr, Cincinnati, OH, 2 Children’s Memorial Hospital, Chicago, IL, 3 Cincinnati Children’s Hospital, Cincinnati, OH, 4 Cohen Children’s Hospital Medical Center, New Hyde Park, NY, 5 Nationwide Childrens Hosp, Columbus, OH, 6 MetroHealth Medical Center, Cleveland, OH, 7 The Hospital for Sick Children, Toronto, ON, 8 University of Chicago, Chicago, IL, 9 Medical College of Wisconsin, Milwaukee, WI, 10 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH, 11 Childrens Hospital of New York, Columbia University Medical Center, New York, NY, 12 BC Childrens Hospital, Vancouver, BC, 13 Duke University Medical Center, Durham, NC, 14 Texas Scottish Rite Hospital, Dallas, TX, 15 Okla Univ Health Science Ctr, Oklahoma City, OK, 16 PRINTO-IRCCS, Genova, Italy 2015. A Secondary Analysis of the Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) Study Shows That Atorvastatin Therapy Reduces Progression of Carotid Intima Medial Thickening in Pubertal SLE Patients with Higher C Reactive Protein. Stacy P. Ardoin 1 , Laura E. Schanberg 2 , Christy I. Sandborg 3 , Huiman Barnhart 4 , Eric Yow 4 , Greg Evans 5 , Kelly Mieszkalski 2 , Norman T. Ilowite 6 , Emily von Scheven 7 , B. Anne Eberhard 8 , Lisa F. Imundo 9 , Deborah M. Levy 10 , Yuki Kimura 11 , Earl D. Silverman 12 , Suzanne L. Bowyer 13 , Marilynn G. Punaro 14 , Nora G. Singer 15 , David D. Sherry 16 , Deborah K. McCurdy 17 , Marisa Klein- Gitelman 18 , Carol A. Wallace 19 , Richard M. Silver 20 , Linda Wagner-Weiner 21 , Gloria Higgins2 2 and Hermine Brunner 23 , 1 Ohio State University, Columbus, OH, 2 Duke University Medical Center, Durham, NC, 3 Stanford University, Palo Alto, CA, 4 Duke Clinical Research Institute, Durham, NC, 5 Winston-Salem, NC, 6 Children’s Hospital Montefiore, Bronx, NY, 7 UC San Francisco, San Francisco, CA, 8 Cohen Children’s Hospital Medical Center, New Hyde Park, NY, 9 Childrens Hospital of New York, Columbia University Medical Center, New York, NY, 10 The Hospital for Sick Children, Toronto, ON, 11 Pediatrics, Hackensack, NJ, 12 Hospital for Sick Children, Toronto, ON, 13 James Whitcomb Riley Hospital, Indianapolis, IN, 14 Texas Scottish Rite Hospital, Dallas, TX, 15 Director, Division of Rheumatology, MetroHealth Medical Center, Case Western Reserve University, Cleveland, OH, 16 Children’s Hospital of Philadelphia, Philadelphia, PA, 17 Mattel Children’s Hospital, University of California, Los Angeles, Los Angeles, CA, 18 Children’s Memorial Hospital, Chicago, IL, 19 Childrens Hosp & Regional Med, Seattle, WA, 20 MUSC, Charleston, SC, 21 University of Chicago Hospital, Chicago, IL, 22 NATIONWIDE CHILDRENS HOSPITAL, Columbus, OH, 23 Cincinnati Children’s Hospital Medical Center, Cincinnati, OH 2016. Ovarian Reserve in Juvenile Systemic Lupus Erythematosus Patients without Amenorrhea. Nadia E. Aikawa 1 , Adriana M. Sallum 2 , Rosa M.R. Pereira 3 , Eloisa Bonfa 4 , Lisa Suzuki 5 , Vilma S.T. Viana 1 and Clovis A. Silva 6 , 1 Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 2 Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo- SP, Brazil, 3 Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil, 4 University of Sao Paulo, Sao Paulo, Brazil, 5 Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil, 6 Instituto da Criança, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil 2017. Maternal Autoimmunity and Neonatal Brain Abnormalities: Cerebral Dysmaturation, Diencephalon Abnormalities, and Lenticulostriate Vasculopathy. Jennifer D. Frankovich 1 , Patrick D. Barnes 1 , Christy I. Sandborg 1 and Eliza F. Chakravarty 2 , 1 Stanford University, Palo Alto, CA, 2 Oklahoma Medical Research Foundation, Oklahoma City, OK 2018. Long-Term Methotrexate Efficacy in Juvenile Localized Scleroderma. Francesco Zulian 1 , Cristina Vallongo 1 , Fabio Vittadello 1 , Annalisa Patrizi 2 , Maria Alessio 3 , Anna Belloni Fortina 1 , Silvana Martino 4 and Giorgia Martini 1 , 1 University of Padua, Padova, Italy, 2 University of Bologna, Bologna, Italy, 3 University of Naples Federico II, Napoli, Italy, 4 University of Turin, Italy 2019. Diagnostic Evaluation and Medication Usage in a Cohort of Subjects with Juvenile Dermatomyositis Recruited within the First 11 Months of the Children’s Arthritis and Rheumatology Research Alliance Registry. Angela B. Robinson 1 , Mark F. Hoeltzel 2 , ML Becker 2 , Dawn M. Wahezi 3 , Adam M. Huber 4 , Brian M. Feldman 5 , Ann M. Reed 6 and Juvenile Myositis CARRA Subgroup for CARRAnet Investigators 7 , 1 Rainbow Babies and Childrens Hospital, Cleveland, OH, 2 Children’s Mercy Hospital, Kansas City, MO, 3 Children’s Hospital Montefiore, Bronx, NY, 4 Dalhousie University, Halifax, NS, 5 The Hospital for Sick Children, Toronto, ON, 6 Mayo Clinic, Rochester, MN, 7 Varies by Investigator 2020. Influenza A H1N1/2009 Vaccine in Juvenile Dermatomyositis: Reduced Response in Patients Under Immunosuppressive Agents. Vanessa R. Guissa 1 , Nadia E. Aikawa 2 , Adriana M. Sallum 1 , Lucia M.A. Campos 3 , Rosa M.R. Pereira 4 , Eloisa Bonfa 5 and Clovis A. Silva 1 , 1 Faculdade de Medicina da Universidade de São Paulo, São Paulo-SP, Brazil, 2 Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, 3 Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, Brazil, 4 Disciplina de Reumatologia da FMUSP, Sao Paulo, Brazil, 5 University of Sao Paulo, São Paulo, Brazil 2021. Creation of A COHORT of French PATIENTS with CHRONIC RECURRENT Multifocal OSTEITIS: PRELIMINARY RESULTS. Julien Wipff 1 , M.-A. Dumitrescu 2 , Mathie Lorrot 3 , Albert Faye 2 , S. lacassagne-Compeyrot 4 , B. Bader Meunier 4 , R. Mouy 4 , Carine H. Wouters 5 , Marine Desjonqueres 6 , S. Jean 7 , V. Despert 7 , A. Duquesne 6 , I. Lemelle 8 , P. Pillet 9 , M. Grall- Lerosey 10 , Pierre Quartier 11 and Chantal Job-Deslandre 12 , 1 Paris descartes Universityn Rheumatology A, Cochin Hospital, Paris, France, 2 Paris, France, 3 Paediatry, Robert Debré hospital, Paris, France, 4 University Paris Descartes, Paediatry, Necker hospital, Paris, France, 5 University 2011 <strong>Program</strong> <strong>Book</strong> 271
- Page 1 and 2:
program B O O K Pre-Conference Cour
- Page 3 and 4:
program B O O K ABOUT ACR/ARHP EDUC
- Page 5 and 6:
TABLE OF CONTENTS POLICIES Copyrigh
- Page 7 and 8:
TABLE OF CONTENTS ACR Immunology Up
- Page 9 and 10:
TABLE OF CONTENTS Vasculitis Poster
- Page 11 and 12:
However, the ACR continues to requi
- Page 13 and 14:
MEETING NAVIGATION GUIDE To navigat
- Page 15 and 16:
Newsroom Located in room W175c, use
- Page 17:
Guided Poster Tours Guided poster t
- Page 20 and 21:
FRIDAY November 4, 2011 9:15 am Ult
- Page 22 and 23:
SATURDAY, NOVEMBER 5, 2011 12:00 -
- Page 24 and 25:
SATURDAY November 5, 2011 8:35 am T
- Page 26 and 27:
SATURDAY November 5, 2011 Pain: Pat
- Page 28 and 29:
SUNDAY November 6, 2011 SUNDAY, NOV
- Page 30 and 31:
SUNDAY November 6, 2011 Upon comple
- Page 32 and 33:
EXHIBITS 10:00 am - 5:00 pm INNOVAT
- Page 34 and 35:
SUNDAY November 6, 2011 ARHP SPECIA
- Page 36 and 37:
SUNDAY November 6, 2011 W179b Rheum
- Page 38 and 39:
3:15 pm 732. Notch Signaling Pathwa
- Page 40 and 41:
SUNDAY November 6, 2011 3:15 pm 756
- Page 42 and 43:
SUNDAY November 6, 2011 Children’
- Page 44 and 45:
SUNDAY November 6, 2011 3:00 pm 791
- Page 46 and 47:
3:30 pm Demonstration and Practice
- Page 48 and 49:
Yasser M. El Miedany 1 , Maha El Ga
- Page 50 and 51:
SUNDAY November 6, 2011 48 Musculos
- Page 52 and 53:
SUNDAY November 6, 2011 5:15 pm 852
- Page 54 and 55:
SUNDAY November 6, 2011 52 4:55 pm
- Page 56 and 57:
MONDAY, NOVEMBER 7, 2011 ACR/ARHP R
- Page 58 and 59:
MONDAY November 7, 2011 W185a Scler
- Page 60 and 61:
MONDAY November 7, 2011 Upon comple
- Page 62 and 63:
Upon completion of this session, pa
- Page 64 and 65:
MONDAY November 7, 2011 W187b Basic
- Page 66 and 67:
MONDAY November 7, 2011 2:30 pm Cel
- Page 68 and 69:
MONDAY November 7, 2011 Indianapoli
- Page 70 and 71:
3:45 pm 1628. Association of Knee P
- Page 72 and 73:
MONDAY November 7, 2011 Glostrup, C
- Page 74 and 75:
MONDAY November 7, 2011 3:33 pm A R
- Page 76 and 77:
MONDAY November 7, 2011 4:30 pm Ris
- Page 78 and 79:
Institutet, Stockholm, Sweden, 6 Un
- Page 80 and 81:
5:45 pm 1700. Successful Dose De-Es
- Page 82 and 83:
MONDAY November 7, 2011 Michigan, A
- Page 84 and 85:
MONDAY November 7, 2011 4:45 pm 172
- Page 86 and 87:
MONDAY November 7, 2011 5:25 pm Imp
- Page 88 and 89:
TUESDAY November 8, 2011 ARHP CONCU
- Page 90 and 91:
TUESDAY November 8, 2011 9:25 am Is
- Page 92 and 93:
ACR PRACTICE ISSUE 9:30 - 10:30 am
- Page 94 and 95:
TUESDAY November 8, 2011 noon 2431.
- Page 96 and 97:
TUESDAY November 8, 2011 W186b Vasc
- Page 98 and 99:
ACR CLINICAL SYMPOSIA 2:30 - 4:00 p
- Page 100 and 101:
TUESDAY November 8, 2011 3:45 pm 24
- Page 102 and 103:
TUESDAY November 8, 2011 University
- Page 104 and 105:
TUESDAY November 8, 2011 and Oncolo
- Page 106 and 107:
Italy, 3 Hospital Universitario La
- Page 108 and 109:
3:10 pm Case Study Diane V. Lacaill
- Page 110 and 111:
• discuss the evidence to support
- Page 112 and 113:
TUESDAY November 8, 2011 4:45 pm 25
- Page 114 and 115:
5:15 pm 2532. Selection of Patients
- Page 116 and 117:
TUESDAY November 8, 2011 ACR/ARHP C
- Page 118 and 119:
WEDNESDAY, NOVEMBER 9, 2011 ACR/ARH
- Page 120 and 121:
9:00 am Mechanisms of Thrombosis in
- Page 122 and 123:
WEDNESDAY November 9, 2011 A. Kopec
- Page 124 and 125:
WEDNESDAY November 9, 2011 9:15 am
- Page 126 and 127:
WEDNESDAY November 9, 2011 9:45 am
- Page 128 and 129:
WEDNESDAY November 9, 2011 11:45 am
- Page 130 and 131:
WEDNESDAY November 9, 2011 Graduate
- Page 132 and 133:
11:00 am The Process: Defining Appr
- Page 134 and 135:
ACR Poster Session A 11. Myocardial
- Page 136 and 137:
ACR Poster Session A 37. Regulation
- Page 138 and 139:
ACR Poster Session A 64. Interleuki
- Page 140 and 141:
ACR Poster Session A Mexico City, M
- Page 142 and 143:
ACR Poster Session A 121. An Analys
- Page 144 and 145:
ACR Poster Session A 146. National
- Page 146 and 147:
ACR Poster Session A 165. Genome-Wi
- Page 148 and 149:
ACR Poster Session A 185. US Examin
- Page 150 and 151:
ACR Poster Session A Jones 1 , Andr
- Page 152 and 153:
ACR Poster Session A Gerald J. D. H
- Page 154 and 155:
ACR Poster Session A 258. Etanercep
- Page 156 and 157:
ACR Poster Session A GA, 6 Hospital
- Page 158 and 159:
ACR Poster Session A 305. Pathway-B
- Page 160 and 161:
ACR Poster Session A 328. Near Miss
- Page 162 and 163:
ACR Poster Session A 351. A Novel M
- Page 164 and 165:
ACR Poster Session A Sugihara 6 , K
- Page 166 and 167:
ACR Poster Session A 398. Rituximab
- Page 168 and 169:
ACR Poster Session A & Johnson Phar
- Page 170 and 171:
ACR Poster Session A 436. Predicted
- Page 172 and 173:
ACR Poster Session A Tomomi Tsuru 1
- Page 174 and 175:
ACR Poster Session A 479. Follow up
- Page 176 and 177:
ACR Poster Session A 496. A Chimeri
- Page 178 and 179:
ACR Poster Session A 518. Associati
- Page 180 and 181:
ACR Poster Session A Piestany, Slov
- Page 182 and 183:
ACR Poster Session A 576. Fn14 Defi
- Page 184 and 185:
ACR Poster Session A 593. Plasma Le
- Page 186 and 187:
ACR Poster Session A 611. Why Do Lu
- Page 188 and 189:
ACR Poster Session A 634. Associati
- Page 190 and 191:
ACR Poster Session A Alarcon-Riquel
- Page 192 and 193:
ACR Poster Session A Laboratories,
- Page 194 and 195:
ACR Poster Session A Movsisyan, Lid
- Page 196 and 197:
ACR Poster Session A Th1 Cells Expa
- Page 198 and 199:
ACR/ARHP Poster Session B College o
- Page 200 and 201:
ACR/ARHP Poster Session B 920. Econ
- Page 202 and 203:
ACR/ARHP Poster Session B Study. A.
- Page 204 and 205:
ACR/ARHP Poster Session B 974. Dise
- Page 206 and 207:
ACR/ARHP Poster Session B 1001. Mic
- Page 208 and 209:
ACR/ARHP Poster Session B 206 Khann
- Page 210 and 211:
ACR/ARHP Poster Session B 208 Pulmo
- Page 212 and 213:
ACR/ARHP Poster Session B Swearinge
- Page 214 and 215:
ACR/ARHP Poster Session B 212 Felds
- Page 216 and 217:
ACR/ARHP Poster Session B 214 Corbi
- Page 218 and 219:
ACR/ARHP Poster Session B 1161. End
- Page 220 and 221:
ACR/ARHP Poster Session B 1182. Uri
- Page 222 and 223: ACR/ARHP Poster Session B 1205. A S
- Page 224 and 225: ACR/ARHP Poster Session B 222 Murth
- Page 226 and 227: ACR/ARHP Poster Session B San Diego
- Page 228 and 229: ACR/ARHP Poster Session B 1266. Eva
- Page 230 and 231: ACR/ARHP Poster Session B 1296. Pat
- Page 232 and 233: ACR/ARHP Poster Session B 230 1320.
- Page 234 and 235: ACR/ARHP Poster Session B 1348. Syn
- Page 236 and 237: ACR/ARHP Poster Session B 1375. Ant
- Page 238 and 239: ACR/ARHP Poster Session B 1398. Cli
- Page 240 and 241: ACR/ARHP Poster Session B Baltimore
- Page 242 and 243: ACR/ARHP Poster Session B 1451. Ele
- Page 244 and 245: ACR/ARHP Poster Session B Sclerosis
- Page 246 and 247: ACR/ARHP Poster Session B 1496. Evi
- Page 248 and 249: ACR/ARHP Poster Session B 1518. Pro
- Page 250 and 251: ACR/ARHP Poster Session B Hagen 1 ,
- Page 252 and 253: ACR/ARHP Poster Session B ARHP Clin
- Page 254 and 255: ACR/ARHP Poster Session C Karl Eger
- Page 256 and 257: ACR/ARHP Poster Session C Tampere S
- Page 258 and 259: ACR/ARHP Poster Session C 256 1 Jun
- Page 260 and 261: ACR/ARHP Poster Session C Universit
- Page 262 and 263: ACR/ARHP Poster Session C 1864. Epi
- Page 264 and 265: ACR/ARHP Poster Session C 262 Hospi
- Page 266 and 267: ACR/ARHP Poster Session C 2 Biogen
- Page 268 and 269: ACR/ARHP Poster Session C 1945. Cir
- Page 270 and 271: ACR/ARHP Poster Session C 268 1974.
- Page 274 and 275: ACR/ARHP Poster Session C Hosp Gast
- Page 276 and 277: ACR/ARHP Poster Session C Toronto,
- Page 278 and 279: ACR/ARHP Poster Session C Francisco
- Page 280 and 281: ACR/ARHP Poster Session C 2105. Inc
- Page 282 and 283: ACR/ARHP Poster Session C Universit
- Page 284 and 285: ACR/ARHP Poster Session C 282 2151.
- Page 286 and 287: ACR/ARHP Poster Session C 284 2175.
- Page 288 and 289: ACR/ARHP Poster Session C 286 2196.
- Page 290 and 291: ACR/ARHP Poster Session C 2217. Lon
- Page 292 and 293: ACR/ARHP Poster Session C Research
- Page 294 and 295: ACR/ARHP Poster Session C 2258. sIL
- Page 296 and 297: ACR/ARHP Poster Session C 2290. The
- Page 298 and 299: ACR/ARHP Poster Session C Universit
- Page 300 and 301: ACR/ARHP Poster Session C 2345. IL-
- Page 302 and 303: ACR/ARHP Poster Session C 2376. Gra
- Page 304 and 305: ACR/ARHP Poster Session C 2399. Spe
- Page 306 and 307: REF Industry Roundtable-supported S
- Page 308 and 309: REF Industry Roundtable-supported S
- Page 310 and 311: Industry-supported POST-CONFERENCE
- Page 312 and 313: CERTIFICATES OF CME CREDIT OR PARTI
- Page 314 and 315: 2011 ACR/ARHP Annual Meeting Leader
- Page 316 and 317: 2011 ACR/ARHP Annual Meeting Leader
- Page 318 and 319: EXHIBITORS Abbott Pharmaceuticals B
- Page 320 and 321: EXHIBITORS Lippincott, Williams and
- Page 322 and 323:
acknowledgements The ACR, the ARHP
- Page 324 and 325:
Invited Speaker /Moderator Index 32
- Page 326 and 327:
Invited Speaker /Moderator Index 32
- Page 328 and 329:
Invited Speaker /Moderator Index Ev
- Page 330 and 331:
Invited Speaker /Moderator Index 32
- Page 332 and 333:
Invited Speaker /Moderator Index 33
- Page 334 and 335:
Invited Speaker /Moderator Index Mu
- Page 336 and 337:
Invited Speaker /Moderator Index Om
- Page 338 and 339:
Invited Speaker /Moderator Index St
- Page 340 and 341:
Invited Speaker /Moderator Index Wi
- Page 342 and 343:
aBSTRACT author Index 340 Alpers, C
- Page 344 and 345:
aBSTRACT author Index Bawa, WA 259
- Page 346 and 347:
aBSTRACT author Index 344 Broder, A
- Page 348 and 349:
aBSTRACT author Index 346 Chaves, L
- Page 350 and 351:
aBSTRACT author Index 348 Dalbeth,
- Page 352 and 353:
aBSTRACT author Index Eastman, PS 3
- Page 354 and 355:
aBSTRACT author Index 352 Fragoso-L
- Page 356 and 357:
aBSTRACT author Index Gordon, C 4,
- Page 358 and 359:
aBSTRACT author Index Hemmati, I 13
- Page 360 and 361:
aBSTRACT author Index 358 Ishigatsu
- Page 362 and 363:
aBSTRACT author Index 360 Keeling,
- Page 364 and 365:
aBSTRACT author Index 362 Kumar, V
- Page 366 and 367:
aBSTRACT author Index 364 Lim, M 13
- Page 368 and 369:
aBSTRACT author Index 366 Marshall,
- Page 370 and 371:
aBSTRACT author Index 368 MMF/AZA L
- Page 372 and 373:
aBSTRACT author Index 370 Noel, D 1
- Page 374 and 375:
aBSTRACT author Index 372 Pawlita,
- Page 376 and 377:
aBSTRACT author Index 374 Ramos, I
- Page 378 and 379:
aBSTRACT author Index 376 Rönnblom
- Page 380 and 381:
aBSTRACT author Index 378 Shaykevic
- Page 382 and 383:
aBSTRACT author Index Su, J 22, 139
- Page 384 and 385:
aBSTRACT author Index 382 Tomcik, M
- Page 386 and 387:
aBSTRACT author Index 384 Villeneuv
- Page 388 and 389:
aBSTRACT author Index 386 Wu, X 650
- Page 390 and 391:
abstract keyword Index 388 18FDG PE
- Page 392 and 393:
abstract keyword Index 2092, 2113,
- Page 394 and 395:
abstract keyword Index 392 macropha
- Page 396 and 397:
abstract keyword Index 387, 388, 38
- Page 398 and 399:
Abstract Moderator disclosure A Ano
- Page 400 and 401:
Abstract Moderator disclosure Jonas
- Page 402 and 403:
V van der Heijde, Desiree, MD, PhD
- Page 404 and 405:
Notes 402 2011 Program Book
- Page 406 and 407:
immunosuppressive agents is not rec
- Page 408:
In appropriate patients with psoria